Not Signed In -
Multiple System Atrophy |
|
|
Multiple system atrophy (MSA) is a degenerative neurological disorder characterized by a combination of the following: Progressive damage to the autonomic nervous system, commonly leading to low blood pressure upon standing, difficulty urinating, and/or abnormal breathing during sleep Muscle rigidity +/- tremor and slow movement (Parkinsonism) Poor coordination / unsteady walking (ataxia) When autonomic failure predominates, the term Shy-Drager Syndrome is often used. MSA is associated wit ...
Wikipedia - [full article]
Multiple System Atrophy Clinical Trials
- Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy
ClinicalTrials.gov Identifier: NCT00103597 - Completed
Parkinson's Disease; Multiple System Atrophy; Orthostatic Hypotension
- L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions With Carbidopa and Entacapone
ClinicalTrials.gov Identifier: NCT00547911 - Recruiting
Parkinson Disease; Multiple System Atrophy; Autonomic Nervous System Diseases
- Diagnosis and Natural History Study of Patients with Neurological Conditions
ClinicalTrials.gov Identifier: NCT00001549 - Completed
Alzheimer's Disease; Dementia; Movement Disorder; Multiple System Atrophy; Parkinson's Disease
- Study About Efficacy and Safety to Treat Multi-System-Atrophy
ClinicalTrials.gov Identifier: NCT00146809 - Completed
Multi-System-Atrophy; Minocycline
- Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System
ClinicalTrials.gov Identifier: NCT00155168 - Recruiting
Spinal Muscular Atrophy
- Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
ClinicalTrials.gov Identifier: NCT00368199 - Recruiting
Parkinson's Disease; Parkinsonian Syndrome; Multiple System Atrophy; Supranuclear Palsy, Progressive; Essential Tremor; Vascular Parkinsonism; Drug Induced Parkinsonism
- Research of Biomarkers in Parkinson Disease
ClinicalTrials.gov Identifier: NCT00465790 - Not yet recruiting
Parkinson Disease; Multiple System Atrophy; Progressive Supranuclear Palsy; Huntington Disease; Dystonia; Diffuse Lewy Body Disease
- A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy
ClinicalTrials.gov Identifier: NCT00083746 - Active, not recruiting
Spinal Muscular Atrophy
- DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy
ClinicalTrials.gov Identifier: NCT00429806 - Active, not recruiting
Vaginal Atrophy
- Measuring Levels of SMN in Blood Samples of SMA Patients
ClinicalTrials.gov Identifier: NCT00061607 - Active, not recruiting
Spinal Muscular Atrophy
- A Pilot Theraputic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients
ClinicalTrials.gov Identifier: NCT00568698 - Active, not recruiting
Muscular Atrophy, Spinal
- VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women
ClinicalTrials.gov Identifier: NCT00453089 - Not yet recruiting
Vaginal Atrophy; Vulvar Atrophy
- A Pilot Therapeutic Trial Using Hydroxyurea in Type II and III Spinal Muscular Atrophy Patients
ClinicalTrials.gov Identifier: NCT00084006 - Active, not recruiting
Spinal Muscular Atrophy
- Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
ClinicalTrials.gov Identifier: NCT00227266 - Active, not recruiting
Spinal Muscular Atrophy
- A Pilot Theraputic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
ClinicalTrials.gov Identifier: NCT00568802 - Active, not recruiting
Muscular Atrophy, Spinal
- Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
ClinicalTrials.gov Identifier: NCT00303446 - Active, not recruiting
Kennedy's Disease; Spinal and Bulbar Muscular Atrophy
- A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00276094 - Recruiting
Vulvar and Vaginal Atrophy in Postmenopausal Women
- Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00002787 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00429936 - Recruiting
Macular Degeneration; Atrophy
- A Randomized, Double-Blind, Placebo-Controlled Trial of Hydroxyurea in Spinal Muscular Atrophy
ClinicalTrials.gov Identifier: NCT00485511 - Recruiting
Spinal Muscular Atrophy
- Study to Evaluate Sodium Phenylbutyrate in Pre-Symptomatic Infants With Spinal Muscular Atrophy
ClinicalTrials.gov Identifier: NCT00528268 - Recruiting
Spinal Muscular Atrophy
- Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
ClinicalTrials.gov Identifier: NCT00211224 - Terminated
Multiple System Atrophy; Progressive Supranuclear Palsy
- Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
ClinicalTrials.gov Identifier: NCT00481013 - Recruiting
Spinal Muscular Atrophy
- Muscle Atrophy in Sepsis
ClinicalTrials.gov Identifier: NCT00583206 - Recruiting
Atrophy; Sepsis; Weakness
- A Study to Evaluate Rituximab in Adults with Relapsing Remitting Multiple Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00097188 - Active, not recruiting
Multiple Sclerosis
- Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00088855 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004903 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Bortezomib in Combination with CC-5013 in Patients with Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00153933 - Active, not recruiting
Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003490 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
ClinicalTrials.gov Identifier: NCT00439569 - Not yet recruiting
Spinal Muscular Atrophy Type II; Spinal Muscular Atrophy Type III
- Combination Chemotherapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002678 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Clinical Study of Spinal Muscular Atrophy
ClinicalTrials.gov Identifier: NCT00443066 - Recruiting
Spinal Muscular Atrophy
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00306488 - Recruiting
Bilateral Geographic Atrophy; Age-Related Macular Degeneration; AMD
- Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
Multiple Sclerosis
- Melphalan, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003954 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Safety of RG2077 in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
- Combination Chemotherapy With or Without Thalidomide in Treating Patients With Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005834 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.
ClinicalTrials.gov Identifier: NCT00154960 - Recruiting
Spinal Muscular Atrophy; Neonatal Hyperbilirubinemia; Colon Cancer
- Phase III Randomized Study of Melphalan With or Without Holmium Ho 166 DOTMP Followed By Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00008229 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
Multiple Sclerosis
- Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
Multiple Sclerosis
- T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant
ClinicalTrials.gov Identifier: NCT00048464 - Active, not recruiting
Multiple Myeloma
- Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003603 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Effect of Exercise on Risk-Factors of Elderly Women
ClinicalTrials.gov Identifier: NCT00267839 - Active, not recruiting
Atrophy
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005792 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients with Relapsed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00080405 - Active, not recruiting
Multiple Myeloma
- Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00040937 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006219 - Active, not recruiting
Multiple Myeloma
- Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006890 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00014508 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00095680 - Active, not recruiting
Multiple Myeloma
- A Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00087529 - Active, not recruiting
Multiple Sclerosis
- High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
ClinicalTrials.gov Identifier: NCT00002630 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Safety and efficacy of single-agent CC-5013 in subjects with relapsed and refractory multiple myeloma
ClinicalTrials.gov Identifier: NCT00065351 - Active, not recruiting
Multiple Myeloma
- Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00002850 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection
- Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I
ClinicalTrials.gov Identifier: NCT00439218 - Not yet recruiting
Spinal Muscular Atrophy Type I
- VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients with Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00111319 - Active, not recruiting
Multiple Myeloma
- Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00024466 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Auditory Function in Patients With and Without Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037947 - Recruiting
Multiple Sclerosis
- Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00103974 - Active, not recruiting
Multiple Sclerosis
- Study of Oral SCIO-469 in Relapsed, Refractory Patients with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00087867 - Active, not recruiting
Multiple Myeloma
- A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041 for Treatment of Vulvovaginal Atrophy
ClinicalTrials.gov Identifier: NCT00361569 - Active, not recruiting
Menopause
- Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004158 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; stage I multiple myeloma; refractory plasma cell neoplasm
- Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00021359 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002653 - Active, not recruiting
Multiple Myeloma
- Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004165 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis
- Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049673 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002548 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
ClinicalTrials.gov Identifier: NCT00113919 - Active, not recruiting
Multiple Myeloma
- Thal/Dex (Thalidomide and Dexamethasone) vs. Dd-T (Doxil, Dexamethasone and Thalidomide) in Multiple Myeloma Patients
ClinicalTrials.gov Identifier: NCT00097981 - Active, not recruiting
Multiple Myeloma
- Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004088 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- R115777 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00021203 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Melphalan and Prednisone With or Without Bortezomib in Treating Older Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00109902 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon alfa in Treating Patients With Advanced Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006244 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00057564 - Active, not recruiting
Multiple Myeloma
- Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00045136 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00411723 - Recruiting
Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
- Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00075881 - Active, not recruiting
stage III multiple myeloma
- CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00056160 - Active, not recruiting
Multiple Myeloma
- Study of DOXIL/CAELYX and VELCADE or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00103506 - Active, not recruiting
Multiple Myeloma
- Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00151203 - Active, not recruiting
Multiple Myeloma
- EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00137176 - Recruiting
Multiple Sclerosis
- EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00146068 - Recruiting
Multiple Sclerosis
- Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00220493 - Recruiting
Relapsing Remitting Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
- Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis With Optional Extension Phase
ClinicalTrials.gov Identifier: NCT00340834 - Active, not recruiting
Multiple Sclerosis
- Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00316940 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00186238 - Active, not recruiting
Multiple Myeloma
- Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
ClinicalTrials.gov Identifier: NCT00186316 - Active, not recruiting
Multiple Myeloma
- Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00246324 - Active, not recruiting
Multiple Sclerosis
- GER-009-06-AVX Early Therapy in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00492570 - Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
- Reproducibility of the aCGH System Using Whole Blood Samples
ClinicalTrials.gov Identifier: NCT00214448 - Not yet recruiting
Multiple genetic conditions will be studied.
- Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00317811 - Active, not recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Extension Study to Evaluate Safety, Tolerability and Effects on Efficacy Parameters of FTY720 in Patients With Relapsing Multiple Sclerosis.
ClinicalTrials.gov Identifier: NCT00235430 - Active, not recruiting
Multiple Sclerosis
- Prospective, Open-Label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
ClinicalTrials.gov Identifier: NCT00262314 - Active, not recruiting
Multiple Sclerosis
Resources
- Catch a Rapid Killer: Research for Multiple System Atrophy (Cleveland Clinic)
- Multiple System Atrophy (National Institute of Neurological Disorders and Stroke)
email this page
print this page
bookmark this page
feedback on this page
